Belgium

On January 19, 2021, the 2021 tariffs for APR-DRG groups, as well as the distribution of total amount within DRG among all specialists and services which are provided by them, were published. Except for the update of the tariffs, no other changes were introduced within the Belgian DRG system.

On January 19, 2021, Belgian Health Care Knowledge Center (KCE) published a health services research report "Barriers and facilitators for eHealth adoption by general practitioners”. Findings from the research show that there is a wide range of factors contributing to the uptake of eHealth technology by healthcare professionals. These factors range from the quality of the eHealth technology, use, and user satisfaction, net benefits, individual, organizational, and implementation characteristics to country-specific factors (such as governance, standards, funding, or trends).

On January 20, 2021, the National Institute for Health and Disability Insurance (INAMI-RIZIV) announced the reimbursement pathway for health apps. Health apps can now reach level M3 of the validation pyramid.

On December 22, 2020, the National Institute for Health and Disability Insurance (INAMI-RIZIV) announced a pilot project which concerns the remote monitoring of COVID-19 patients before and after their hospitalization as part of an integrated medical approach supported by digital applications.

Belgian Health Care Knowledge Center (KCE) initiated the health services research on facilitators and barriers for e-Health adoption by general practitioners. The project has been started in 2017 and is still ongoing.

The Belgian Health Care Knowledge Center (KCE) is conducting research towards a faster, substantiated decision on the reimbursement of innovative medical products. The project started in 2019 and is still being conducted.

New material codes and related conditions of reimbursement for anchoring and fixation implants for soft tissue were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in August 2020.

New material codes and related conditions of reimbursement for middle ear implants were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) in August 2020.

In September 2020, the list of companion diagnostic tests, which are evaluated for reimbursement, was updated. INAMI has a specific reimbursement framework for companion diagnostic tests. INAMI Nomenclature codes from Article 33ter can only be reimbursed in relation to specific biomarker tests and drugs from Chapter VIII of the reimbursable pharmaceutical specialties (Royal Decree of February 1, 2018).

In August 2020, mHealthBelgium announced two more health application accomplished M2 validation - Well@Home and AirView. After achieving M2 level, developers will get access to more options, like risk assessment framework, test centers, a lot of useful information.

In July 2020, new material code and related conditions of reimbursement concerning the endoscopic treatment of primary or secondary vesicoureteral reflux were added to the List of reimbursable devices of the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV).

In July 2020, two new apps entered the level 1 of the mHealthBelgium validation pyramid. Healthentia is an eClinical platform to record Real World Data, that can be used either in clinical trials or by healthy individuals. Sunrise (class IIa) sleep testing device allows rapid and at home diagnosing respiratory sleep disorders.